Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Application of LiveSpo Navax in Treatment of Acute Respiratory Disease in Children Infected With Respiratory Syncytial Virus

NCT05164692 is registered in ClinicalTrials.gov with National Children's Hospital, Vietnam as lead sponsor.

NCT NCT05164692
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05164692 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Application of LiveSpo Navax in Treatment of Acute Respiratory Disease in Children Infected With Respiratory Syncytial Virus
Lead sponsor
National Children's Hospital, Vietnam
Phase
Not applicable
Overall status
Completed
Start date
August 29, 2020
Completion date
August 29, 2021
Enrollment
100 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute respiratory tract infections